Member Info for bobbust

If the do this simple invasive test and 60% of the time they find out something about the cancer they will take that.

Combo checkpoint inhibitors freely given out with at best 50% success which has horrible side effects (unless given with SCLP's scib1 which increases ORR to 85%)

High winds and warm weather should be goo for GOODs profit

Have seen the above then had a look at HMI my thought is this will need a discounted raise in the near future.

Is that a correct assumption?

Https://www.telegraph.co.uk/business/2023/12/23/scramble-uranium-supplies-new-nuclear-silk-road/

Looks like we could come up smelling of roses

Also Golden metal could be doing a re-rate soon

Profit taking due to the share price rise is understandable given the rise but this is still under valued.

Loss this quarter is less than projected.

Cash was £35m, unlike to change a great deal. MC still only £54m.

That's a lot of company for £19m

Positive result in every hole

And nothing!!!

For over 3m

Pictures of the drill core on twitter. looks good

https://x.com/MarcFCMetals/status/1734125731209207895?s=20

But come on it's not 6 months ago.

Money is getting a bit easier to get.

Ok why is this so bad it warrants a drop on 40% to historic lows?

The potential here is huge.

Surface shows

A company 10km away is building a processing plant.

This could be a mine in a very short space of time

And at a very low Capx

These guys don't hang about.

Drilling has started.

Only shallow as the stuff is showing at ground level.

The raise puts us in a stronger position because they raised the cash so quickly and easily.

It would not surprise me if when talking to big pharma they said we'll you only have cash for a year, you need a deal we want a discount.

That's gone.

Did anyone notice JMC said pharma wanted 30 patients?

Deal could be sooner than expected

All very positive.

New starts are very bright, young and very enthusiastic. All the team spoke very highly.

Dr Mandeep has been there 3 months. lets give her a chance.

SCIB 1

the intresting thing was the up lift for 9 out of 11 to 11 out of 13 did not include patient 2 (24% reduction) they have not been rescaned as yet. If they do shrink tumour to more then 30% ORR would be 92%

Inital delay in recrutment was due to trying to use only patients on a single CPI. this is no longer standard care.

Modi 1

ongoing with good recrutment.

As a monotherapy ORR of about 60%. similar to SCIB1

With double CPI should again be similar to SCIB 1

will concentrate on cancers with aproved CPI treatments

Deals could come at any time for Glymab at any time.

Enough cash there till meaning full results in

Great chat with the lads at Mines and money today

They are very positive

Looking forward to getting a rig onsite

Bit of a jump!!

If they do a fund raise so what. The last was at a small discount to the SP at the time.

Money will be needed to advance current projects.

Near term results could prove a major inflection point and provide the SP a proper re-rate

They will make $16 for the year at present numbers .

MC £48.

That's not a bad ratio given more wells coming on site.

Growth company so ratio very good.

I know it's jam tomorrow but feel confident